Abstract
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials.
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Alzheimer's & Dementia: Translational Research & Clinical Interventions
Paper Title
Journal
Date